TREATMENT OF PARKINSON'S DISEASE WITH AMANTADINE AND LEVODOPA: A One-year Study
- 29 May 1971
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 297 (7709), 1083-1087
- https://doi.org/10.1016/s0140-6736(71)91834-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- AMANTADINE IN PARKINSONISMThe Lancet, 1970
- Use of Amantadine in Parkinson's Disease. Results of a Double-blind TrialBMJ, 1970
- Potentiation by amantadine hydrochloride of L-dopa-induced effects in miceJournal of Pharmacy and Pharmacology, 1970
- AMANTADINE DOSAGE IN TREATMENT OF PARKINSON'S DISEASEThe Lancet, 1970
- AMANTADINE IN PARKINSONISMThe Lancet, 1970
- CONTROLLED TRIAL OF AMANTADINE HYDROCHLORIDE IN PARKINSON'S DISEASEThe Lancet, 1970
- The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa.Journal of Neurology, Neurosurgery & Psychiatry, 1970
- Fluorimetric determination of 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluidClinica Chimica Acta; International Journal of Clinical Chemistry, 1969
- EFFECTS OF L-DOPA IN PARKINSON'S DISEASEThe Lancet, 1969
- Amantadine in the Treatment of Parkinson's DiseaseJAMA, 1969